TherapeuticsMD Inc. (TXMD)
Symbol Info
Listed Symbol TXMD
Name TherapeuticsMD Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $16,099,460
Latest Fiscal EPS $-0.59
Price Info
21 Day Moving Average $2.3886
21 Day EMA $2.554680
50 Day Moving Average $2.5078
50 Day EMA $2.679750
200 Day EMA $3.909320
200 Day Moving Average 4.127700
52 Week High $6.94
52 Week Low $1.82
52 Week Change $-48.468502
Alpha -0.007119
Beta 1.6108
Standard Deviation 0.174375
R2 0.102727
Periods 60
Share Information
10 Day Average Volume 5,240,603
20 Day Average Volume 3,984,336
30 Day Average Volume 3,397,007
50 Day Average Volume 3,858,131
Outstanding Shares 241,221,840
Float Shares 216,866,922
Percent Float 89.90%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 269
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 15,030,938
Institute Holdings Percent -
Institute Sold Previous 3 Months 14,492,239
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 2,408
Insider Holdings Percent 10.10%
Insider Sold Previous 3 Months -
Insiders Shares Owned 24,354,918
Price Change
7 Day Price Change $-0.24
7 Day Percent Change -7.74%
21 Day Price Change $0.6399999
21 Day Percent Change 28.83%
30 Day Price Change $0.4099999
30 Day Percent Change 16.73%
Month To Date Price Change $0.7100
Month To Date Percent 33.02%
90 Day Price Change $-0.59
90 Day Percent Change -17.10%
Quarter To Date $0.260000
Quarter To Date Percent 10.00%
180 Day Price Change $-2.79
180 Day Percent Change -49.38%
200 Day Price Change $-2.21
200 Day Percent Change -43.59%
Year To Date $-0.95
Year To Date Percent -24.93%
Profile
Description TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Details
Issue Type CS
Market Cap $689,894,462
Sec Type EQS
Auditor Grant Thornton LLP
Total Shares Outstanding 241,221,840
CEO Robert G. Finizio
Employees 241
Last Audit UQ
Classification
CIK 0000025743
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 6800 Broken Sound Parkway NW
Third Floor
Boca Raton, FL 33487
Website http://www.therapeuticsmd.com
Facisimile
Telephone +1 561 961-1900
Email Nochsner@TherapeuticsMD.com
Key Ratios
Profitability
EBIT Margin -857.9
EBITDA Margin -855.8
Pre-Tax Profit Margin -505.9
Profit Margin Cont -
Gross Margin 80.30
Profit Margin TOT -
Income Statements
Revenue $18,588,574
Revenue Per Share $0.0771
Revenue 3 Years $-4.32
Revenue 5 Years $3.45
Valuation Measures
PE Ratio -
Enterprise Value $731,352,913
Price To Sales 37.113895
Price To Free Cash -4.1
PE High Last 5 Years -
Price To Book 88.5
Price To Cash Flow 0.4
PE Low Last 5 Years -
Price To Tangible Book -43.2
Financial Strength
Total Debt To Equity 24.4
Int Coverage -15.5
Current Ratio 5.2
Leverage Ratio 2.9
Quick Ratio 4.8
Long Term Debt To Capital 0.96
Assets
Receivables Turnover 1.0
Invoice Turnover 0.80
Assets Turnover -
Management Effectiveness
Return Assets -81.13
Return On Equity -396.41
Return On Capital -89.16
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
TXMD
Therapeuti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.